Chemoradiation with gemcitabine for cervical cancer in patients with renal failure

Anti-Cancer Drugs

Volumn 15, Issue 8, 2004, Pages 761-766

  Cetina, Lucely ^a   Rivera, Lesbia ^a   Candelaria, Myrna ^a   De La Garza, Jaime ^a   Duenas Gonzalez, Alfonso ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Cervical cancer; Gemcitabine; Renal dysfunction

Indexed keywords

CISPLATIN; CREATININE; GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; COLITIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DERMATITIS; DYSURIA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INFECTION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOPENIA; NAUSEA; NEUTROPENIA; OBSTRUCTIVE UROPATHY; PERCUTANEOUS NEPHROSTOMY; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; SIDE EFFECT; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; URETER OBSTRUCTION; UTERINE CERVIX CANCER;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CREATININE; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MEXICO; MIDDLE AGED; NEOPLASM STAGING; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TREATMENT OUTCOME; URETHRAL OBSTRUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 4644318305     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200409000-00004     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden. Globocan 2000. Int J Cancer 2001; 94:153-156.
2. Duenas-Gonzalez A, Cetina L, Mariscal I, de la Garza J. Modem management of locally advanced cervical carcinoma. Cancer Treat Rev 2003; 29:389-399.
3. Hopkins M, Worley G. Prognostic factors in advanced stage squamous cell cancer of the cervix. Cancer 1993; 72:2389-2393.
4. Logsdon MD, Eifel PJ. RGO stage IIIB squamous cell carcinoma of the cervix:an analysis of prognostics factors emphasizing the balance between external beam radiation and intracavitary radiation therapy. Int J Radiother Oncol Biol Phys 1999; 43:763-775.
5. Lee S, Jones H W. Prognostic significance of ureteral obstruction in primary cervical cancer. Int J Gynecol Obstet 1994; 44:59-65.
6. Brin E, Schiff M, Weiss R. Palliative urinary diversion for pelvic malignancy. J Urol 1975; 113:619-22.
7. Shekarriz B, Shekarriz H, Upadhyay J, Banerjee M, Becker H, Pontes JE, et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 1999; 85:999-1003.
8. Chua DT, Iliya FA, O'Leary JA, Veenema RJ, Frick 2nd HC. Palliative urinary diversion in patients with advanced carcinoma of the cervix. Cancer 1967; 20:93-95.
9. Taylor P, Andersen W. Untreated cervical cancer complicated by obstructive uropathy and oliguric renal failure. Gynecol Oncol 1981; 11:162-174.
10. Meyer J, Yatsuhashi M, Green T. Palliative urinary diversion in patients with advanced pelvic malignancy. Cancer 1980; 45:2698-2701.
11. Duenas-Gonzalez A, Cetina L, Sanchez B, Gomez E, Rivera L, Hinojosa J, et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int J Radiat Oncol Biol Phys 2003; 56:1361-1365.
12. Hernandez P, Olivera P, Duenas-Gonzalez A, Perez-Pastenes MA, Zarate A, Maldonado V, et al. Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 2001; 48:488-492.
13. Duenas-Gonzalez A, Lopez Graniel C, Gonzalez A, Reyes M, Mota A, Munoz D, et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untrate locally advanced cervical carcinoma. Ann Oncol 2001; 12:541-547.
14. Pattaranutapom P, Thirapakawong C, Chansilpa Y, Therasakvichya S, leumwananontachai N, Thephamongkhol K. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 2000; 81:404-407.
15. Zarba JJ, Jaremtchuk AV, Gonzalez Jazey P, Keropian M, Castagnino R, Mina C, et al. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol 2003; 14:1285-1290.
16. Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, et al. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol 2000; 18:2780-2787.
17. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997; 38:969-978.
18. Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995; 35:107-117.
19. Kovalic JJ, Perez CA, Grigsby PW, Lockert MA. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991; 21:905-910.
20. Lanciano RM, Martz K, Coia LR, Hanks GE. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys 1991; 20:95-100.
21. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 1986; 57:148-54.
22. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis. Lancet 2001; 358:781-786.
23. Cerrotta A, Gardan G, Cavina R, Raspagliesi F, Stefanen B, Garassino I, et al. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose. Eur J Gynaecol Oncol 2002; 23:115-119.
24. Dunton CJ, King SA, Neufeld J, Tolosa J, Perez G, Avila A, et al. Phase I study of topotecan and radiation therapy in advanced cervical cancer. Gynecol Oncol 2002; 85:185-187.
25. Suntornpong N, Pattaranutaporn P, Chanslip Y, et al. Concurrent radiation therapy and irinotecan in stage IIIB cervical cancer. J Med Assoc Thai 2003; 86:430-435
26. Mutch DG, Bloss JD. Gemcitabine in cervical cancer. Gynecol Oncol 2003; 90:8-15.
27. Meyer J, Green T, Yatsuhasshi M. Palliative urinary diversion in carcinoma of the cervix. Obstet Gynecol 1980; 55:95-98.
28. Carter J, Ramirez C, Waugh R, Atkinson K, Coppleson M, Elliott P, et al. Percutaneous urinary diversion in gynecologic oncology. Gynecol Oncol 1991; 40:248-252.
29. Mann Jr WJ, Jander HP, Orr Jr JW, Taylor PT, Hatch KD, Shingleton HM. The use of percutaneous nephrostomy in gynecologic oncology. Gynecol Oncol 1980; 10:343-349.
30. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 1998; 69:137-145.